|
| 36302166 | Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population. | Blood | 2023 |
| 37190862 | Long non-coding RNAs associated with transcriptomic signatures and treatment outcome in diffuse large B-cell lymphoma. | Br J Haematol | 2023 |
| 35078860 | Targeting Refractory Mantle Cell Lymphoma for Imaging and Therapy Using C-X-C Chemokine Receptor Type 4 Radioligands. | Clin Cancer Res | 2022 |
| 35380993 | Tumor-associated antigen PRAME exhibits dualistic functions that are targetable in diffuse large B cell lymphoma. | J Clin Invest | 2022 |
| 35685639 | Distinct Gene Expression Patterns of Calcium Channels and Related Signaling Pathways Discovered in Lymphomas. | Front Pharmacol | 2022 |
| 35111387 | CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2: Characterizing CD4+ T cells in Hodgkin lymphoma. | Oncoimmunology | 2022 |
| 32961552 | Mutational landscape of gray zone lymphoma. | Blood | 2021 |
| 34615710 | Single-cell profiling reveals the importance of CXCL13/CXCR5 axis biology in lymphocyte-rich classic Hodgkin lymphoma. | Proc Natl Acad Sci U S A | 2021 |
| 34583126 | Improved resolution of phenotypic subsets in human T-ALL by incorporation of RNA-seq based developmental profiling. | Leuk Res | 2021 |
| 33963000 | Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer. | Clin Cancer Res | 2021 |
| 34168051 | Combined EZH2 Inhibition and IKAROS Degradation Leads to Enhanced Antitumor Activity in Diffuse Large B-cell Lymphoma. | Clin Cancer Res | 2021 |
| 33120427 | The impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHC. | Blood | 2021 |
| 32516416 | Gene expression profiling of gray zone lymphoma. | Blood Adv | 2020 |
| 31857391 | Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma. | Cancer Discov | 2020 |
| 32094924 | TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma. | Nat Med | 2020 |
| 30665349 | BPG: Seamless, automated and interactive visualization of scientific data. | BMC Bioinformatics | 2019 |
| 31501550 | Probabilistic cell-type assignment of single-cell RNA-seq for tumor microenvironment profiling. | Nat Methods | 2019 |
| 31292115 | Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma. | Blood | 2019 |
| 29467182 | Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation. | Blood | 2018 |
| 30348671 | High-resolution architecture and partner genes of <i>MYC</i> rearrangements in lymphoma with DLBCL morphology. | Blood Adv | 2018 |
| 30275490 | Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma. | Nat Commun | 2018 |
| 28086803 | Compendium of TCDD-mediated transcriptomic response datasets in mammalian model systems. | BMC Genomics | 2017 |
| 27166360 | Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma. | Blood | 2016 |
| 26647218 | Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas. | Clin Cancer Res | 2016 |
| 27268263 | Comprehensive characterization of programmed death ligand structural rearrangements in B-cell non-Hodgkin lymphomas. | Blood | 2016 |
| 25378466 | flowDensity: reproducing manual gating of flow cytometry data by automated density-based cell population identification. | Bioinformatics | 2015 |
| 26549456 | Genomic Alterations in CIITA Are Frequent in Primary Mediastinal Large B Cell Lymphoma and Are Associated with Diminished MHC Class II Expression. | Cell Rep | 2015 |
| 26005866 | Spatial genomic heterogeneity within localized, multifocal prostate cancer. | Nat Genet | 2015 |
| 25173705 | SeqControl: process control for DNA sequencing. | Nat Methods | 2014 |
| 25467400 | Cross-species transcriptomic analysis elucidates constitutive aryl hydrocarbon receptor activity. | BMC Genomics | 2014 |
| 25456371 | Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study. | Lancet Oncol | 2014 |
| 23791969 | Validating reference genes within a mouse model system of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) toxicity. | Chem Biol Interact | 2013 |
| 22342509 | Inter-strain heterogeneity in rat hepatic transcriptomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). | Toxicol Appl Pharmacol | 2012 |